All Peptides

Body Protective Compound studied for tissue repair, gut health, and recovery.

Lower-dose BPC-157 vial for shorter research protocols.

Thymosin Beta-4 fragment researched for cellular repair and inflammation modulation.

Lower-dose TB-500 vial for targeted research cycles.

Growth hormone releasing hormone analogue without DAC for pulsatile research.

Heptapeptide researched for cognitive performance and neuroprotection.

Higher-dose Semax vial for extended cognitive and neuroprotective research.

Copper peptide researched for skin, hair, and tissue regeneration.

High-dose copper peptide for extended skin, hair, and tissue regeneration research.

Long-acting amylin analogue researched for appetite and metabolic regulation.

Triple agonist (GLP-1/GIP/Glucagon) studied for advanced metabolic and weight regulation.

Higher-dose Retatrutide for extended metabolic research cycles.

Maximum-dose Retatrutide for long research cycles.

Melanotan-1 researched for melanogenesis and photoprotection.

Melanotan-2 researched for melanogenesis and appetite pathways.

Nicotinamide adenine dinucleotide researched for cellular energy and longevity.

High-dose NAD+ for extended cellular energy and longevity research.

GHRH analogue researched for visceral fat reduction and metabolic profile.

High-dose GHRH analogue for extended metabolic and body composition research.

Skin and rejuvenation blend (GHK-Cu, BPC-157, TB-500, KPV) for cellular renewal research.

Mitochondrial peptide researched for metabolic flexibility and energy regulation.

High-dose mitochondrial peptide for extended metabolic and energy research.

Skin, hair, and cellular vitality blend (GHK-Cu, BPC-157, TB-500).

Copper tripeptide researched for hair follicle activity and scalp health.

Selective ghrelin receptor agonist researched for GH pulsatility.

Blend of CJC-1295 (5mg) without DAC and Ipamorelin (5mg) for combined GH research.

Tripeptide derivative of α-MSH researched for inflammation and gut health.

Neuropeptide researched for reproductive hormone signaling and HPG axis activity.

Mitochondria-targeted peptide researched for cellular energy and oxidative stress.

NNMT inhibitor researched for metabolic regulation and adipose tissue science.

Long-acting insulin-like growth factor 1 analogue researched for tissue growth.

Blend of BPC-157 (5mg) and TB-500 (5mg) for combined repair research.

Higher-dose blend of BPC-157 (10mg) and TB-500 (10mg) for extended repair research.

Dual GIP/GLP-1 agonist studied for advanced metabolic and weight research.

Higher-dose dual GIP/GLP-1 agonist for extended metabolic research.

High-dose dual GIP/GLP-1 agonist for long-cycle research.

Maximum-dose dual GIP/GLP-1 agonist for extended long-cycle research.

Delta sleep-inducing peptide researched for sleep quality and stress regulation.